Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review
- 13 September 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 73 (12), 1523-1537
- https://doi.org/10.1007/s00228-017-2325-0
Abstract
Drug-induced oral lichenoid reactions (DIOLRs) have been extensively reported in the literature, but the validity of the causality relationship between any drug and the oral lichenoid lesions (OLLs) still remains questionable. We sought to determine whether this causality relationship really exists, whether a resolution of the oral lesions upon withdrawal occurs, and what the most common alleged offending medications are.Keywords
This publication has 29 references indexed in Scilit:
- Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition?Clinical and Experimental Dermatology, 2010
- Drug-induced oral lichenoid reactions. A literature reviewJournal of Clinical and Experimental Dentistry, 2010
- Oral manifestations of adverse drug reactions: guidelinesJournal of the European Academy of Dermatology and Venereology, 2008
- Methods for Causality Assessment of Adverse Drug ReactionsDrug Safety, 2008
- Naproxen-induced lichen planus: report of 55 casesInternational Journal of Dermatology, 2006
- Persistent nicorandil induced oral ulcerationHeart, 2004
- Drug reactions involving the mouthClinics in Dermatology, 1986
- Primary biliary cirrhosis and lichen planusJournal of the American Academy of Dermatology, 1983
- DRUG REACTIONS XVIBritish Journal of Dermatology, 1971